Gary Warren

Gary Warren currently serves as president and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in health care. Starting ivWatch in 2010, Gary assembled a team of leading scientists, clinicians, hospitals and investors to solve a common drug delivery problem of IV infiltration and extravasation. Gary has guided ivWatch through multiple  ISO audits and FDA clearances for this breakthrough technology with ivWatch products now being sold on the international market.

Gary has a multidisciplinary background with a 14-year career as a research scientist at NASA in aerospace and computational fluid dynamics. He departed NASA to start a successful Internet infrastructure company in the mid-1990s and served as CEO until it’s sale to Symantec in 1999. At Symantec, Gary served as a senior vice president and oversaw advanced technologies, mergers and acquisitions and gateway software products. He also served as a member of the senior executive staff. After Symantec, Gary served as CEO for a venture-backed mobile platform company as smartphones were beginning to emerge as a market. After the sale of this company to Oracle, Gary worked for various venture capital companies doing financial analysis and due diligence which brought him to the work being done on IV infiltrations under a National Institutes of Health (NIH) grant. Since bringing over the core engineering talent and founding the company, Gary has grown ivWatch to an award-winning brand in health care that is setting a new standard in IV therapy care.

Kathy Cox

Kathy Cox is the Chief Financial Officer overseeing the accounting and finance functions at ivWatch. She joined the company in June 2021 with a history of helping businesses drive growth and implementing operational improvements while building strong and efficient teams. Kathy brings an array of professional financial and operational experiences with companies privately owned and those held by global publicly-traded parent companies. Her industry experience includes medical device manufacturing, healthcare, software, and public accounting. Kathy is a CPA with over 23 years of experience, with the past 15 years spent in the medical device manufacturing and healthcare markets.

Prior to joining ivWatch, Kathy held a series of executive positions for 12 years within Solesis, an operating division of Michelin and Fenner PLC, including Director/General Manager and Finance Director at Charter Medical and Finance Director at Xeridiem Medical Devices.

Jaclyn Lautz, PhD

Jaclyn Lautz is responsible for oversight of research and development, manufacturing, human resources and operations. She leads all product development and innovation efforts for ivWatch, including directing the engineering teams on the design and development of new products and working across departments to bring new products to the market.

Jaclyn joined ivWatch in 2018 from Pricewaterhouse Coopers (PwC) where she was an advisory manager in the pharmaceutical and life sciences operations practice. Prior to that, Jaclyn was ivWatch’s Director of Regulatory Affairs & Quality Assurance and also held several biomedical engineer positions. Jaclyn has a Ph.D. in mechanical engineering & materials science from Duke University where she worked with industry partners on new medical devices and treatment strategies for urological diseases. Her work is published in several physics and medical journals. She was awarded the NSF Graduate Research Fellowship and the NSF Engineering Innovation Fellowship for her graduate studies at Duke University.

Erin Wendell

Erin Wendell, the Chief Marketing Officer at ivWatch, leads the strategic vision and direction for ivWatch’s global branding and messaging, digital presence, internal and external communications and experiential marketing. Erin oversees all aspects of the company’s global brand marketing strategy. Erin has successfully built global marketing communications initiatives, directives and experiences for nearly 15 years.

Prior to beginning work at ivWatch, she served as the Senior Director of Global Communications at Under Armour. At Under Armour, she played a critical role in growing the communications function from its inception, driving brand awareness, executing entries into global markets, launching major campaigns and products and establishing best in class media and employee communications practices.

Holly Novak

Holly Novak is responsible for ensuring compliance to all applicable standards and leads the ivWatch Quality Management System (QMS). Prior to joining ivWatch, Holly has spent the past 15 years in various roles within R&D, Production and Quality Assurance for products that required both USDA and FDA clearance.

In her most recent positions, Holly implemented and maintained an ISO compliant Quality Management System for a medical device company, and more recently for a global supplier of raw materials that served the pharmaceutical, device, government agencies and university markets. She also played an instrumental role in attaining CE marking for the entire product line for Maine Standards Company, a market leader for linearity and calibration verification products.

Chris Pridgen

Chris Pridgen is the Vice President of North American Sales for ivWatch. Chris serves as an integral part of the ivWatch executive team where he leads the Sales representatives and Clinical Specialists. He is responsible for account management with both current and future hospital partnerships and spearheads revenue growth for the organization. His team is actively on the front lines working with champions at hospitals to support the adoption of ivWatch technology. He joined ivWatch in January of 2023 from a tenured 17-year career at Medtronic. He most recently served as the Mid-Atlantic Sales Manager overseeing sales and clinical representatives where he was responsible for multi-million-dollar accounts for a specialized product. Prior to Medtronic he served in various leadership roles at Stryker and Steris earning him nearly 30 years of experience and 23+ in medical. Chris is a graduate from East Carolina University and holds a B.A. in Sociology and a minor in Communications.  Chris brings a wealth of medical sales knowledge that will help drive revenue growth in the United States and Canada.